PGRCX
Price
$57.63
Change
-$0.00 (-0.00%)
Updated
Sep 6 closing price
RPEBX
Price
$59.87
Change
-$0.00 (-0.00%)
Updated
Sep 6 closing price
Ad is loading...

PGRCX vs RPEBX

Header iconPGRCX vs RPEBX Comparison
Open Charts PGRCX vs RPEBXBanner chart's image
BNY Mellon Worldwide Growth C
Price$57.63
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
American Funds New Perspective R2E
Price$59.87
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
PGRCX vs RPEBX Comparison Chart
Loading...
VS
PGRCX vs. RPEBX commentary
Sep 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGRCX is a StrongBuy and RPEBX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPEBX has more cash in the bank: 142B vs. PGRCX (1.14B). RPEBX pays higher dividends than PGRCX: RPEBX (0.46) vs PGRCX (0.11). PGRCX was incepted earlier than RPEBX: PGRCX (29 years) vs RPEBX (10 years). RPEBX is a more actively managed with annual turnover of: 17.00 vs. PGRCX (8.87). RPEBX has a lower initial minimum investment than PGRCX: RPEBX (250) vs PGRCX (1000). RPEBX annual gain was more profitable for investors over the last year : 16.17 vs. PGRCX (11.88). RPEBX return over 5 years is better than : 40.91 vs. PGRCX (29.62).
PGRCXRPEBXPGRCX / RPEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence29 years10 years-
Gain YTD8.24414.31258%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.14B142B1%
Annual Yield % from dividends0.110.4623%
Returns for 1 year11.8816.1773%
Returns for 3 years-8.35-8.06104%
Returns for 5 years29.6240.9172%
Returns for 10 years17.7162.2328%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SY0.840.06
+7.68%
So-Young International
PSN98.222.76
+2.89%
Parsons Corp
FA19.560.28
+1.45%
First Advantage Corp
HEPA0.740.01
+1.11%
Hepion Pharmaceuticals
TTI2.82-0.02
-0.70%
TETRA Technologies